¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 4Dzg r,V  
'")' h  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 4KxuSI^q  
O{c#&/.K  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© Zp[>[1@+  
Lbrn8,G\  
1.Co-stimulators (or co-stimulating molecules) &Hf%Va[B  
Sx~mc_ekY  
2.NK-kB +<@1)qZ(E  
~eP~c"L  
3.Immunoglobulin superfamily =os!^{p7>  
E[ -yfP~[  
4.antigen-presenting cell (APC) ZR=i*y  
cr0/.Zv)  
5.death domain 46 0/eW\  
Rq2bj _j  
6.CCR and CXCR !a V:T&6  
>\'}&oi  
7.Lectin (or mitogen) Lf a&JKd  
+6+1N)L  
8.Clusters of differentiation, CD) vnbY^ASdw  
3zfiegY@wm  
9.B7 family VFq\{@- %  
NODg_J~T  
10.Cytotoxic T lymphocyte, CTL) 32j#kJW  
]{| l4e4P  
11.IL-15 and IL-15 receptor (IL-15R) oWDn_GnG`h  
Pu!C,7vUQ  
12.MHC restriction {=!BzNMj  
%F-yF N"  
13.Affinity-chromatography 0#Q]>V@rO4  
D}ZPgt#   
14.Cyctosprin A, CsA h{~GzrL*  
d[;&2Jz*  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) +-V4:@  
{~\:4  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© ND e FY  
uE,T Ea9;  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 TEK#AR  
YD~(l-?"  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ /bC@^Y&}  
L&5zr_  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ :Xx7':5  
n:<Xp[;R  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Z#;\Rb.x7  
8-O: e  
ÃâÒßѧרҵ£º oO;< $wx2t  
O]25 { L  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ --`W1!jI@  
[#:yOZt  
Ïû»¯ÄÚ¿Æ£º 4]cr1K ^  
|;C;d"JC2  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ fL&e ^Q  
lqoVfj'6M  
ѪҺ²¡Ñ§×¨Òµ£º {]y!2r  
_oU~S$hO  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
4+6=? ÕýÈ·´ð°¸:10
°´"Ctrl+Enter"Ö±½ÓÌá½»